RxDoctor Payments Data

Daniel Zelac, MD

MOHS-Micrographic Surgery · la Jolla, CANPI 1891709903

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $31,502 of the $43,312 with a category attached, or 72.7%. 35 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 48.2% of the total. Reporting peaked in 2022 at $18,279 and has fallen 89.9% since, to $1,853 in 2025. Among mohs-micrographic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,312in general payments, 2019–2025

Across 234 payments — averaging $185.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$21K
  • Sanofi$17K
  • Integra Lifesciences Corporation$686
  • Johnson & Johnson$565
  • E.r. Squibb & Sons, L.L.C.$494
  • Lilly USA, LLC$479
  • plus $3K from 29 others

What the payments were for

  • Speaking & faculty fees$31,50273%
  • Travel & lodging$5,35212%
  • Food & beverage$5,56813%
  • Education$3231%
  • Other$5671%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,312 in reported general payments places this provider in the 95th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$467,890
Medicare patients
647
Services billed
2,656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil43$3,115
Minoxidil83$960
Dutasteride20$650
Clobetasol Propionate12$537
Imiquimod14$531
Doxycycline Hyclate50$357
Cephalexin85$317
Finasteride23$307
Ketoconazole18$274
Mupirocin25$234
Spironolactone31$229
Triamcinolone Acetonide31$218

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in la Jolla

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →